Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Eir
  6. /
  7. Avadim Holdings Inc
EIR
•Avadim Holdings Inc•November 4, 2016

Avadim Holdings Inc – FDA EIR, Nov 4, 2016

Record Details

A routine FDA inspection of Avadim Technologies Inc., a company formulating, selling, and distributing Over-the-Counter (OTC) drug topical products, was conducted from November 1-4, 2016. The inspection identified five significant observations, several of which were repeat issues from a prior inspection of the predecessor entity, Avadim, LLC.

Main violations included the absence of written procedures for production and process controls designed to assure drug product identity, strength, quality, and purity, particularly concerning finished product testing. The quality control unit demonstrated inadequate adherence to its responsibilities, evidenced by incomplete deviation and customer complaint documentation, a lack of scientific rationale for root cause investigations, improper labeling of released products, and insufficient review of contract manufacturer records, leading to the approval of products made with expired components. Outdated marketing materials were also commingled with current ones.

Further issues involved the lack of a formal written program to assess drug product stability, hindering proper expiration date determination. Procedures to prevent objectionable microorganisms in non-sterile drug products were not established, including validation of bioburden reduction and a written program for microbial testing. Finally, the company lacked established procedures for warehousing drug products, evidenced by uncontrolled temperature in sample storage and facility deficiencies.

These observations indicated non-compliance with regulatory requirements, primarily under Current Good Manufacturing Practice (21 CFR Part 211). Avadim Technologies Inc. was instructed to submit a formal response to the FDA's findings within 15 working days.

Company
Avadim Holdings Inc
Inspection date
November 4, 2016
Product type
OTC (Over-the-Counter)
Office
Atlanta District Office
Person
  • Constance Y. Fears (issuing_officer)
View Company Profile

ID · 1962dd02-f6b4-4d83-8f62-0df6f6d1fef5

Violation Codes6
21 CFR 211.100(a)21 CFR 211.166(a)21 CFR 200-29921 CFR 211.113(a)21 CFR 211.14221 CFR 211.22(d)

Full citation text and observation details available on the Dashboard.

Other documents for Avadim Holdings Inc
  • 483 - 2025-05-22May 22, 2025
  • EIR - 2019-03-06March 6, 2019

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Avadim Holdings Inc
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.